These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1446862)

  • 1. Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique.
    Lo SK; Fleming KA; Chapman RW
    Gut; 1992 Oct; 33(10):1370-5. PubMed ID: 1446862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.
    Duerr RH; Targan SR; Landers CJ; LaRusso NF; Lindsay KL; Wiesner RH; Shanahan F
    Gastroenterology; 1991 May; 100(5 Pt 1):1385-91. PubMed ID: 2013383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis.
    Seibold F; Slametschka D; Gregor M; Weber P
    Gastroenterology; 1994 Aug; 107(2):532-6. PubMed ID: 8039629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis.
    Haagsma EB; Mulder AH; Gouw AS; Horst G; Meerman L; Slooff MJ; Kallenberg CG
    J Hepatol; 1993 Aug; 19(1):8-14. PubMed ID: 8301047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment.
    Oudkerk Pool M; Ellerbroek PM; Ridwan BU; Goldschmeding R; von Blomberg BM; Peña AS; Dolman KM; Bril H; Dekker W; Nauta JJ
    Gut; 1993 Jan; 34(1):46-50. PubMed ID: 8432451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease.
    Peen E; Almer S; Bodemar G; Rydén BO; Sjölin C; Tejle K; Skogh T
    Gut; 1993 Jan; 34(1):56-62. PubMed ID: 8432453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineutrophil antibody: a test for autoimmune primary sclerosing cholangitis in childhood?
    Lo SK; Chapman RW; Cheeseman P; Charlton CP; Walker-Smith JA; Mieli-Vergani G; Fleming KA
    Gut; 1993 Feb; 34(2):199-202. PubMed ID: 8432473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.
    Snook JA; Chapman RW; Fleming K; Jewell DP
    Clin Exp Immunol; 1989 Apr; 76(1):30-3. PubMed ID: 2786779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis.
    Pokorny CS; Norton ID; McCaughan GW; Selby WS
    J Gastroenterol Hepatol; 1994; 9(1):40-4. PubMed ID: 8155865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.
    Seibold F; Weber P; Klein R; Berg PA; Wiedmann KH
    Gut; 1992 May; 33(5):657-62. PubMed ID: 1612483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens?
    Seibold F; Weber P; Schöning A; Mörk H; Goppel S; Scheurlen M
    Eur J Gastroenterol Hepatol; 1996 Nov; 8(11):1095-100. PubMed ID: 8944372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis.
    Vidrich A; Lee J; James E; Cobb L; Targan S
    J Clin Immunol; 1995 Nov; 15(6):293-9. PubMed ID: 8576315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
    Mulder AH; Horst G; Haagsma EB; Limburg PC; Kleibeuker JH; Kallenberg CG
    Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques.
    Bansi DS; Bauducci M; Bergqvist A; Boberg K; Broome U; Chapman R; Fleming K; Jorgensen R; Lindor K; Rosina F; Schrumpf E
    Eur J Gastroenterol Hepatol; 1997 Jun; 9(6):575-80. PubMed ID: 9222729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass.
    Bansi DS; Fleming KA; Chapman RW
    Gut; 1996 Mar; 38(3):384-9. PubMed ID: 8675091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass.
    Bansi D; Chapman R; Fleming K
    J Hepatol; 1996 May; 24(5):581-6. PubMed ID: 8773914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis.
    Hardarson S; Labrecque DR; Mitros FA; Neil GA; Goeken JA
    Am J Clin Pathol; 1993 Mar; 99(3):277-81. PubMed ID: 8447289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative colitis.
    Bansi DS; Lo S; Chapman RW; Fleming KA
    Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):111-6. PubMed ID: 8723413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis.
    Orth T; Kellner R; Diekmann O; Faust J; Meyer zum Büschenfelde KH; Mayet WJ
    Clin Exp Immunol; 1998 Jun; 112(3):507-15. PubMed ID: 9649223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.